Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy

Serological cell death biomarkers and circulating tumor cells (CTCs) have potential uses as tools for pharmacodynamic blood-based assays and their subsequent application to early clinical trials. In this study, we evaluated both the expression and clinical significance of CTCs and serological cell d...

Full description

Saved in:
Bibliographic Details
Main Authors: Hou, Jian-Mei, Greystoke, Alastair, Lancashire, Lee, Cummings, Jeff, Ward, Tim, Board, Ruth, Amir, Eitan, Hughes, Sarah, Krebs, Matthew, Hughes, Andrew, Ranson, Malcolm, Lorigan, Paul, Dive, Caroline, Blackhall, Fiona H.
Format: Artigo
Language:Inglês
Published: American Society for Investigative Pathology 2009
Subjects:
Regular Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2716975/
https://ncbi.nlm.nih.gov/pubmed/19628770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/ajpath.2009.090078
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items